These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 16874671

  • 21. Electrolyte mass balance during CVVH: lactate vs. bicarbonate-buffered replacement fluids.
    Tan HK, Uchino S, Bellomo R.
    Ren Fail; 2004 Mar; 26(2):149-53. PubMed ID: 15287198
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Continuous veno-venous hemofiltration using a phosphate-containing replacement fluid in the setting of regional citrate anticoagulation.
    Morabito S, Pistolesi V, Tritapepe L, Vitaliano E, Zeppilli L, Polistena F, Fiaccadori E, Pierucci A.
    Int J Artif Organs; 2013 Dec; 36(12):845-52. PubMed ID: 24362894
    [Abstract] [Full Text] [Related]

  • 25. [Insufficient correction of blood bicarbonate levels in biguanide lactic acidosis treated with CVVH and bicarbonate replacement fluids].
    Mariano F, Goia F, Vincenti R, Capra L, Lanza G, Curto V, Cavalli PL.
    Minerva Urol Nefrol; 1997 Sep; 49(3):133-6. PubMed ID: 9432735
    [Abstract] [Full Text] [Related]

  • 26. Bench-to-bedside review: treating acid-base abnormalities in the intensive care unit--the role of renal replacement therapy.
    Naka T, Bellomo R.
    Crit Care; 2004 Apr; 8(2):108-14. PubMed ID: 15025771
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. A comparison of two citrate anticoagulation regimens for continuous veno-venous hemofiltration.
    Egi M, Naka T, Bellomo R, Cole L, French C, Trethewy C, Wan L, Langenberg CC, Fealy N, Baldwin I.
    Int J Artif Organs; 2005 Dec; 28(12):1211-8. PubMed ID: 16404696
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Hyperlactatemia Predicts Citrate Intolerance With Regional Citrate Anticoagulation During Continuous Renal Replacement Therapy.
    Tan JN, Haroon SWP, Mukhopadhyay A, Lau T, Murali TM, Phua J, Tan ZY, Lee N, Chua HR.
    J Intensive Care Med; 2019 May; 34(5):418-425. PubMed ID: 28372501
    [Abstract] [Full Text] [Related]

  • 34. Fluid overload before continuous hemofiltration and survival in critically ill children: a retrospective analysis.
    Foland JA, Fortenberry JD, Warshaw BL, Pettignano R, Merritt RK, Heard ML, Rogers K, Reid C, Tanner AJ, Easley KA.
    Crit Care Med; 2004 Aug; 32(8):1771-6. PubMed ID: 15286557
    [Abstract] [Full Text] [Related]

  • 35. Hypophosphatemia during continuous veno-venous hemofiltration is associated with mortality in critically ill patients with acute kidney injury.
    Yang Y, Zhang P, Cui Y, Lang X, Yuan J, Jiang H, Lei W, Lv R, Zhu Y, Lai E, Chen J.
    Crit Care; 2013 Sep 19; 17(5):R205. PubMed ID: 24050634
    [Abstract] [Full Text] [Related]

  • 36. Regional citrate anticoagulation in CVVH: a new protocol combining citrate solution with a phosphate-containing replacement fluid.
    Morabito S, Pistolesi V, Tritapepe L, Zeppilli L, Polistena F, Fiaccadori E, Pierucci A.
    Hemodial Int; 2013 Apr 19; 17(2):313-20. PubMed ID: 22882732
    [Abstract] [Full Text] [Related]

  • 37. Differences in CVVH vs. CVVHDF in the management of sepsis-induced acute kidney injury in critically ill patients.
    Premuzic V, Basic-Jukic N, Jelakovic B, Kes P.
    J Artif Organs; 2017 Dec 19; 20(4):326-334. PubMed ID: 28676904
    [Abstract] [Full Text] [Related]

  • 38. Metabolic effects of citrate- vs bicarbonate-based substitution fluid in continuous venovenous hemofiltration: a prospective sequential cohort study.
    Aman J, Nurmohamed SA, Vervloet MG, Groeneveld AB.
    J Crit Care; 2010 Mar 19; 25(1):120-7. PubMed ID: 19427760
    [Abstract] [Full Text] [Related]

  • 39. Cost analysis of two modalities of continuous renal replacement therapy.
    Duriseti P, Idrees N, Aldairem A, Jaber BL, Balakrishnan VS.
    Hemodial Int; 2021 Apr 19; 25(2):173-179. PubMed ID: 33103356
    [Abstract] [Full Text] [Related]

  • 40. Strong ion difference and CVVH: Different response during nadroparin versus citrate anticoagulation.
    Buter H, Koopmans M, van der Voort PHJ.
    J Crit Care; 2018 Oct 19; 47():88-92. PubMed ID: 29936328
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.